Literature DB >> 30007228

Generation of a T cell receptor (TCR)-like single domain antibody (sDAb) against a Mycobacterium Tuberculosis (Mtb) heat shock protein (HSP) 16kDa antigen presented by Human Leukocyte Antigen (HLA)-A*02.

Sylvia Annabel Dass1, Mohd Nor Norazmi2, Armando Acosta Dominguez2, Maria Elena Sarmiento Garcia San Miguel2, Gee Jun Tye3.   

Abstract

The discovery of heat shock protein 16 kDa antigen protein has deepen the understanding of latent tuberculosis since it was found to be primarily expressed by Mycobacterium tuberculosis during latent phase leading to the rapid optimization and development in terms of diagnosis and therapeutics. Recently, T cell receptor-like antibody has been explored extensively targeting various diseases due to its dual functionality (T cell receptor and antibody). In this study, a TCR-like domain antibody (A2/Ab) with the binding capacity to Mtb heat shock protein (HSP) 16 kDa antigen presented by major histocompatible complex (MHC) HLA-A*02 was successfully generated via biopanning against human domain antibody library. The generated antibody (A2/Ab) exhibited strong functionality and binding capacity against the target assuring the findings of this study to be beneficial for the development of latent tuberculosis diagnosis and immunotherapeutics in future.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibody phage display; Immunosurveillance; Immunotherapy; Latent tuberculosis; T cell receptor-like antibody

Mesh:

Substances:

Year:  2018        PMID: 30007228     DOI: 10.1016/j.molimm.2018.07.001

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

Review 1.  The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy.

Authors:  Sylvia Annabel Dass; Rehasri Selva Rajan; Gee Jun Tye; Venugopal Balakrishnan
Journal:  Hum Vaccin Immunother       Date:  2021-05-14       Impact factor: 3.452

2.  A Direct Role for the CD1b Endogenous Spacer in the Recognition of a Mycobacterium tuberculosis Antigen by T-Cell Receptors.

Authors:  Frank Camacho; Ernesto Moreno; Luis F Garcia-Alles; Glay Chinea Santiago; Martine Gilleron; Aleikar Vasquez; Yee Siew Choong; Fátima Reyes; Mohd Nor Norazmi; Maria E Sarmiento; Armando Acosta
Journal:  Front Immunol       Date:  2020-10-14       Impact factor: 7.561

Review 3.  The COVID-19/Tuberculosis Syndemic and Potential Antibody Therapy for TB Based on the Lessons Learnt From the Pandemic.

Authors:  Sylvia Annabel Dass; Venugopal Balakrishnan; Norsyahida Arifin; Crystale Siew Ying Lim; Fazlina Nordin; Gee Jun Tye
Journal:  Front Immunol       Date:  2022-02-15       Impact factor: 7.561

4.  Role of antibodies in vaccine-mediated protection against tuberculosis.

Authors:  Francesco Dieli; Juraj Ivanyi
Journal:  Cell Mol Immunol       Date:  2022-04-08       Impact factor: 22.096

5.  Selection of a Single Domain Antibody, Specific for an HLA-Bound Epitope of the Mycobacterial Ag85B Antigen.

Authors:  Paola A Ortega; Mayra Silva-Miranda; Alfredo Torres-Larios; Eduardo Campos-Chávez; Kees C L C M Franken; Tom H M Ottenhoff; Juraj Ivanyi; Clara Espitia
Journal:  Front Immunol       Date:  2020-10-02       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.